Home / Blog / When the First Medication Is Not Enough
OCD medication, in plain language
Here is a result nobody warns you about. The medication helped. The obsessions are quieter, the rituals take less of the day, and you are still, unmistakably, struggling. Partly better feels like a verdict: the medicine sort of worked, so maybe this is as good as it gets.
In OCD treatment, partly better is not a verdict. It is a recognized result with a planned next step, and that step has a name: augmentation.
Augmentation means keeping the medication that helped and adding a second one, an augmenting agent, to support it. It is the opposite of starting over. When a medication has already won you real ground, there is a logic to building on it instead of surrendering the gains and beginning again with an unknown.
The augmenting agents used first for OCD are medicines borrowed from other areas of psychiatry, used at low doses for this purpose. They are added one at a time, for a stated reason, and judged the same way everything in OCD treatment here is judged: against your symptom scores, not against a feeling.
Augmentation enters the conversation after an adequate trial. Adequate means the dose reached the range used for OCD and stayed there, with the whole trial running 8 to 12 weeks or more. If the response to that trial was real but incomplete, which prescribers measure with the Y-BOCS scale, augmentation is one of the standard next steps, alongside switching to a second SSRI or to an older tricyclic medication approved for OCD.
It is also the step people most often never hear about. Trials end, partial results get accepted as final, and nobody mentions that the ladder continues.
Adding a first-line augmenting agent helps about a third of people who did not respond adequately to an SSRI alone. A third is not a miracle, and this page will not dress it up as one. It is a real, studied effect, large enough that the guidelines place augmentation among the standard steps after an adequate first trial, which is exactly where it sits on the treatment ladder on our homepage.
The honest limits matter too. Two medications mean two side effect profiles to watch, and some augmenting agents call for metabolic monitoring, the weight, blood sugar, and lipid checks described on our page about lab testing. And about two thirds of people will not get the extra response, which is why augmentation is a step on a ladder and not the top of it.
How does a prescriber choose between adding a medication and switching to a different one? Mostly by asking what the first trial actually produced. A partial response argues for building: the medication found something worth completing. No response at all, or side effects you cannot live with, argues for a switch. How many adequate trials you have already completed matters, and so does your history with each option. There is no formula that replaces that review, which is why it happens in a full audit of your medication history rather than a five minute refill visit.
It is not an experiment improvised at your expense; it is one of the most studied steps in OCD medication care. It is not medication pile-up either. Done properly, it is one change at a time, with a target, a timeline, and a score to check it against, and anything that does not earn its place gets removed.
If you are partly better and nobody has mentioned any of this, that gap is not your failure. Bring your medication history to a prescriber who treats OCD every day, and ask the question directly: was my trial adequate, is my response partial, and if it is, what is the case for augmenting rather than accepting where I am?
Bring your medication history to a Comprehensive Initial Appointment and hear what your partial response actually makes possible.
Book a Comprehensive Initial AppointmentEducational information only, not medical advice. Medication decisions are individual and made after evaluation.
